Physician profile
Girish Venkataraman
NPI 1568625937
$29,517.46
in general payments reported to CMS, 2019-2025
5 companies · $8,691 in 2025
The $8,691 reported for 2025 was more than what 95% of Anatomic Pathology & Clinical Pathology providers received nationally (typical 2025 total: $50.59).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $9,784 · 2020: $6,645 · 2021: $1,620 · 2023: $27.70 · 2024: $2,750 · 2025: $8,691.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $6,500 · Honoraria: $4,738 · Food and Beverage: $226 · Travel and Lodging: $5.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $6,500.00 |
| Honoraria | $4,738.00 |
| Food and Beverage | $225.85 |
| Travel and Lodging | $5.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eusa Pharma (US) LLC | $18,048.61 | 2019-2021 | |
| Recordati_rare_diseases_inc. | $4,941.15 | 2025 | Sylvant |
| Amgen INC. | $3,750.00 | 2025 | Uplizna |
| Leica Microsystems INC. | $2,750.00 | 2024 | Bond-Prime Automated Stainer |
| Boston Scientific Corporation | $27.70 | 2023 | Spyscope Ds |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Girish Venkataraman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.